Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating IFN-γ mediated diseases using human anti-IFN-γ neutralizing antibodies as selective IFN-gamma pathway inhibitors

Methods for treating IFN-γ mediated diseases using human anti-IFN-γ neutralizing antibodies as selective IFN-gamma pathway inhibitors

US Patent 8529893 · Granted Sep 10, 2013

Estimated economic value: $486,590,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fancy box2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Anti-interleukin-23 P19 antibodies and methods of use thereof2025
Interleukin-15 (IL-15) fusion proteins and uses thereof2025
Cytokine-based bioactivatable drugs and methods of uses thereof2025
Interleukin-2 variants and methods of uses thereof2024
Anti-CD27 antibodies and uses thereof2024
Methods of treating non-alcoholic steatohepatitis using FGF21 mutants2023
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) 2023
Stabilized receptor polypeptides and uses thereof2023
Cytokine-based bioactivatable drugs and methods of uses thereof2023
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2022